Company profile for Taiwan Liposome Company

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

TLC is dedicated to the development of novel nanomedicines that maximize the potential of our proprietary LipAD® lipid-assembled delivery system to enable sustained release and/or targeted deliveries that reduce toxicity and improve efficacy. We are a clinical-stage specialty pharmaceutical company dedicated to the development and commercialization of best-in-class novel nanomedicines that combine our proprietary lipid-assemb...
TLC is dedicated to the development of novel nanomedicines that maximize the potential of our proprietary LipAD® lipid-assembled delivery system to enable sustained release and/or targeted deliveries that reduce toxicity and improve efficacy. We are a clinical-stage specialty pharmaceutical company dedicated to the development and commercialization of best-in-class novel nanomedicines that combine our proprietary lipid-assembled drug delivery platform with approved active pharmaceutical ingredients (APIs).

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Taiwan
Address
Address
2F, 3 Yuanqu Street, Nangang District, Taipei 11503
Telephone
Telephone
+886 2 2655 7377
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com//news-release/2023/12/27/2801290/0/en/TLC-to-Present-at-the-42nd-Annual-JP-Morgan-Healthcare-Conference.html

GLOBENEWSWIRE
27 Dec 2023

https://www.globenewswire.com/news-release/2023/11/20/2782968/0/en/Highlights-of-Dr-David-Hunter-s-Oral-Presentation-at-ACR-s-Late-Breaking-Abstracts-Session.html

GLOBENEWSWIRE
20 Nov 2023

https://www.globenewswire.com//news-release/2023/11/08/2775903/0/en/TLC-to-Present-Phase-3-Data-of-TLC599-in-Late-Breaking-Abstracts-Session-at-ACR.html

GLOBENEWSWIRE
08 Nov 2023

https://www.nasdaq.com/articles/stock-alert%3A-taiwan-liposome-gains-30-on-approval-to-initiate-covid-19-treatment-trial

NASDAQ
07 Oct 2020

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty